GSK3B and metabolic dysfunction-associated steatohepatitis: In this study, the expression manner of SIRT1 manifested in line with that of GSK3β, supporting the notion that the GSK3β/SIRT1 axis plays a role in the pathophysiology of NASH and that this axis can be suppressed by miR-29a to exert hepatoprotection.